Recombinant Anti-VEGFR2 x Anti-VEGFR3 Bispecific Antibody (scFv-CH1/CL) (BSCC-191)

Recombinant Anti-VEGFR2 x Anti-VEGFR3 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-VEGFR2 antibody variable domain is fused to CH1 and the other scFv from an anti-VEGFR3 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can block two receptors simultaneously. It is designed for the research of Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

VEGFR2 & VEGFR3

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cancers

Targets

Target 1

VEGFR2

Gene ID

3791

UniProt ID

A0A024RD88

Alternative Names

FLK1; CD309; VEGFR; VEGFR2; Vascular endothelial growth factor receptor 2; Kinase insert domain receptor; Fetal liver kinase 1; Kinase insert domain receptor, a type III receptor; KDR

Target 2

VEGFR3

Gene ID

2324

UniProt ID

P35916

Alternative Names

FLT4; PCL; FLT-4; FLT41; LMPH1A; VEGFR3; VEGFR-3; fms related tyrosine kinase 4; Vascular endothelial growth factor 3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-VEGFR2 x Anti-VEGFR3 Bispecific Antibody (scFv-CH1/CL) (BSCC-191). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-VEGFR2 x Anti-VEGFR3 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-191)

Specifications

Targets

Customer Reviews and Q&As